François de Kermenguy, PhD is a postdoctoral researcher at Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard University, where he is working on a the development and optimization of a new on-board dual-energy imager for patient set-up verification in radiotherapy. François earned his PhD from Gustave Roussy, where he specialized in mathematical modeling of lymphopenia and developed the LymphoDose framework, a novel approach to estimate dose received by circulating lymphocytes during radiotherapy.